Comparative Study
doi: 10.2214/ajr.184.1.01840324. Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapyAffiliations
AffiliationItem in Clipboard
Comparative Study
Detection of breast cancer on screening mammography allows patients to be treated with less-toxic therapyRichard J Barth Jr et al. AJR Am J Roentgenol. 2005 Jan.
doi: 10.2214/ajr.184.1.01840324. AffiliationItem in Clipboard
AbstractObjective: Therapy for breast cancer is accompanied by acute and chronic toxicity. Little research has been conducted to determine the impact of the mode of breast cancer detection on the likelihood of receiving different types of treatment. The objective of this study was to determine whether detection of breast cancer on screening mammography is associated with less-toxic therapy.
Materials and methods: The study group for this retrospective cohort study consisted of 992 women with invasive breast cancer detected on screening mammography (n = 460) or at physical examination (n = 532) at a single institution between 1990 and 2001. To address the generalizability of study findings, we compared the characteristics of study participants with those diagnosed with breast cancer in a population-based mammography registry.
Results: The patients whose breast cancer was detected on screening mammography more frequently had lymph nodes free of metastases (84% vs 58%, p < 0.0001), had smaller tumors (1.5 vs 2.9 cm, p < 0.0001), were more likely to be treated with breast conservation (56% vs 32%, p < 0.0001), and were less likely to be treated with chemotherapy (28% vs 56%, p < 0.0001). In a multivariate analysis with adjustments for age and functional status, patients whose cancer was detected at physical examination were more than twice as likely to undergo mastectomy (odds ratio [OR], 2.5; 95% confidence interval [CI], 1.9-3.3) and nearly three times as likely to be treated with chemotherapy (OR, 2.9; 95% CI, 2.1-3.9). For younger women (40-49 years old), the likelihood of receiving chemotherapy was more than doubled if the cancer was detected at physical examination rather than on screening mammograms (OR, 2.3; 95% CI, 1.3-4.0). For older women (>/= 70 years old), patients whose cancer was detected at physical examination were five times more likely to undergo mastectomy (OR, 5.8; 95% CI, 3.2-10.5) and four times more likely to receive chemotherapy (OR, 4.6; 95% CI, 1.6-13) than the group whose tumors were detected on screening mammography.
Conclusion: Breast cancers detected on screening mammography are smaller, are less likely to metastasize to lymph nodes, and are more likely to be treated with breast conservation and without chemotherapy. These findings provide an additional rationale for performing screening mammography, especially for women at age extremes for whom the survival benefit of screening mammography is debated.
Similar articlesLeung JW. Leung JW. AJR Am J Roentgenol. 2005 May;184(5):1508-9. doi: 10.2214/ajr.184.5.01841508. AJR Am J Roentgenol. 2005. PMID: 15855106
White E, Miglioretti DL, Yankaskas BC, Geller BM, Rosenberg RD, Kerlikowske K, Saba L, Vacek PM, Carney PA, Buist DS, Oestreicher N, Barlow W, Ballard-Barbash R, Taplin SH. White E, et al. J Natl Cancer Inst. 2004 Dec 15;96(24):1832-9. doi: 10.1093/jnci/djh337. J Natl Cancer Inst. 2004. PMID: 15601639
Miller AB, Baines CJ, To T, Wall C. Miller AB, et al. CMAJ. 1992 Nov 15;147(10):1477-88. CMAJ. 1992. PMID: 1423088 Free PMC article. Clinical Trial.
Chuang SL, Chen SL, Yu CP, Chang KJ, Yen AM, Chiu SY, Fann JC, Tabár L, Stephen DW, Smith RA, Chen HH. Chuang SL, et al. APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. APMIS. 2014. PMID: 25046200 Review.
Chiarelli AM, Edwards SA, Sheppard AJ, Mirea L, Chong N, Paszat L, Shumak RS, Oʼmalley FP; Breast Screening Study Group. Chiarelli AM, et al. Eur J Cancer Prev. 2012 Nov;21(6):499-506. doi: 10.1097/CEJ.0b013e328350b0f4. Eur J Cancer Prev. 2012. PMID: 22273849 Review.
Heinig M, Heinze F, Schwarz S, Haug U. Heinig M, et al. BMC Cancer. 2022 Feb 2;22(1):130. doi: 10.1186/s12885-022-09240-w. BMC Cancer. 2022. PMID: 35109813 Free PMC article.
Bula-Ibula D, Carly B, Rozenberg S. Bula-Ibula D, et al. Arch Gynecol Obstet. 2023 May;307(5):1539-1546. doi: 10.1007/s00404-022-06630-0. Epub 2022 Aug 5. Arch Gynecol Obstet. 2023. PMID: 35931900
Klarenbach SW, Moore AE, Thombs BD; Canadian Task Force on Preventive Health Care. Klarenbach SW, et al. CMAJ. 2020 Feb 10;192(6):E146-E147. doi: 10.1503/cmaj.74313. CMAJ. 2020. PMID: 32041702 Free PMC article. No abstract available.
Marmarà D, Marmarà V, Hubbard G. Marmarà D, et al. BMC Public Health. 2018 Jan 25;18(1):182. doi: 10.1186/s12889-018-5093-6. BMC Public Health. 2018. PMID: 29370835 Free PMC article.
Lv X, Yang L, Liu T, Yang Z, Jia C, Chen H. Lv X, et al. Front Surg. 2022 Jul 26;9:922167. doi: 10.3389/fsurg.2022.922167. eCollection 2022. Front Surg. 2022. PMID: 35959119 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3